Clinical Trials
5 trialsNCT05032820 2026-05-19
Upfront Chimeric Antigen Receptor T-Cell to Upgrade Response in Multiple Myeloma
Medical College of Wisconsin
Phase 2 Completed
NCT03601078 2026-03-04
KarMMa-2
Celgene
Phase 2 Completed
NCT03361748 2025-05-23
KarMMa
Celgene
Phase 2 Completed
NCT04196491 2023-08-23
KarMMa-4
Celgene
Phase 1 Completed
NCT02658929 2023-01-23
Study of bb2121 in Multiple Myeloma
Celgene
Phase 1 Completed